{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:41:14Z","timestamp":1791603674963,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.2119\/molmed.2016.00077","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T11:57:50Z","timestamp":1472817470000},"page":"310-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Mutations in the Na+\/Citrate Cotransporter NaCT (SLC13A5) in Pediatric Patients with Epilepsy and Developmental Delay"],"prefix":"10.1186","volume":"22","author":[{"given":"Jenna","family":"Klotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda E","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Schlessinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"2201310_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0883073815599262","volume":"31","author":"S Gursoy","year":"2016","unstructured":"Gursoy S, Ercal D. (2016) Diagnostic approach to genetic causes of early-onset epileptic encephalopathy. J. Child Neurol. 31:523\u201332.","journal-title":"J. Child Neurol."},{"key":"2201310_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajhg.2014.06.006","volume":"95","author":"J Thevenon","year":"2014","unstructured":"Thevenon J, et al. (2014) Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. Am. J. Hum. Genet. 95:113\u201320.","journal-title":"Am. J. Hum. Genet."},{"key":"2201310_CR3","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1093\/brain\/awv263","volume":"138","author":"K Hardies","year":"2015","unstructured":"Hardies K, et al. (2015) Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. Brain. 138:3238\u201350.","journal-title":"Brain"},{"key":"2201310_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1474-4422(15)00148-9","volume":"14","author":"G Zsurka","year":"2015","unstructured":"Zsurka G, Kunz WS. (2015) Mitochondrial dysfunction and seizures: The neuronal energy crisis. Lancet Neurol. 14:956\u201366.","journal-title":"Lancet Neurol."},{"key":"2201310_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0006-291X(02)02669-4","volume":"299","author":"K Inoue","year":"2002","unstructured":"Inoue K, Zhuang L, Ganapathy V. (2002) Human Na+-coupled citrate transporter: Primary structure, genomic organization, and transport function. Biochem. Biophys. Res. Commun. 299:465\u201371.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2201310_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00424-013-1369-y","volume":"466","author":"AM Pajor","year":"2014","unstructured":"Pajor AM. (2014) Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family. Pflugers Arch. 466:119\u201330.","journal-title":"Pflugers Arch."},{"key":"2201310_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1471-4159.2006.03720.x","volume":"97","author":"E Yodoya","year":"2006","unstructured":"Yodoya E, et al. (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J. Neurochem. 97:162\u201373.","journal-title":"J. Neurochem."},{"key":"2201310_CR8","doi-asserted-by":"publisher","first-page":"17777","DOI":"10.1074\/jbc.M111.232744","volume":"286","author":"J Lamp","year":"2011","unstructured":"Lamp J, et al. (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. J. Biol. Chem. 286:17777\u201384.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR9","first-page":"E1","volume":"276","author":"NB Ruderman","year":"1999","unstructured":"Ruderman NB, Saha AK, Vavvas D, Witters LA. (1999) Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276:E1\u201318.","journal-title":"Am. J. Physiol."},{"key":"2201310_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1124\/mol.114.097287","volume":"87","author":"L Li","year":"2015","unstructured":"Li L, et al. (2015) SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. Mol. Pharmacol. 87:674\u201382.","journal-title":"Mol. Pharmacol."},{"key":"2201310_CR11","doi-asserted-by":"publisher","first-page":"17391","DOI":"10.1038\/srep17391","volume":"5","author":"K Huard","year":"2015","unstructured":"Huard K, et al. (2015) Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). Sci. Rep. 5:17391.","journal-title":"Sci. Rep."},{"key":"2201310_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/acs.jmedchem.5b01752","volume":"59","author":"K Huard","year":"2016","unstructured":"Huard K, et al. (2016) Optimization of a dicarboxylic series for in vivo inhibition of citrate transport by the solute carrier 13 (SLC13) family. J. Med. Chem. 59:1165\u201375.","journal-title":"J. Med. Chem."},{"key":"2201310_CR13","doi-asserted-by":"publisher","first-page":"F704","DOI":"10.1152\/ajprenal.00213.2010","volume":"299","author":"AM Pajor","year":"2010","unstructured":"Pajor AM, Sun NN. (2010) Single nucleotide polymorphisms in the human Na+-dicarboxylate cotransporter affect transport activity and protein expression. Am. J. Physiol. Renal Physiol. 299:F704\u201311.","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2201310_CR14","doi-asserted-by":"publisher","first-page":"16998","DOI":"10.1074\/jbc.M114.554790","volume":"289","author":"A Schlessinger","year":"2014","unstructured":"Schlessinger A, Sun NN, Colas C, Pajor AM. (2014) Determinants of substrate and cation transport in the human Na+\/dicarboxylate cotransporter, NaDC3. J. Biol. Chem. 289: 16998\u201317008.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR15","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1021\/bi301611u","volume":"52","author":"AM Pajor","year":"2013","unstructured":"Pajor AM, Sun NN. (2013) Non-steroidal antiinflammatory drugs and other anthranilic acids inhibit the Na+\/dicarboxylate symporter from Staphylococcus aureus. Biochemistry. 52:2924\u201332.","journal-title":"Biochemistry"},{"key":"2201310_CR16","doi-asserted-by":"publisher","first-page":"18728","DOI":"10.1074\/jbc.M501265200","volume":"280","author":"AM Pajor","year":"2005","unstructured":"Pajor AM, Randolph KM. (2005) Conformationally sensitive residues in extracellular loop 5 of the Na+\/dicarboxylate co-transporter. J. Biol. Chem. 280:18728\u201335.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR17","doi-asserted-by":"publisher","first-page":"C1808","DOI":"10.1152\/ajpcell.1996.271.6.C1808","volume":"271","author":"AM Pajor","year":"1996","unstructured":"Pajor AM. Sun N. (1996) Characterization of the rabbit renal Na+\/dicarboxylate cotransporter using anti-fusion protein antibodies. Am. J. Physiol. 271:C1808\u201316.","journal-title":"Am. J. Physiol."},{"key":"2201310_CR18","doi-asserted-by":"publisher","first-page":"20213","DOI":"10.1074\/jbc.M701113200","volume":"282","author":"J Weerachayaphorn","year":"2007","unstructured":"Weerachayaphorn J, Pajor AM. (2007) Sodium-dependent extracellular accessibility of Lys-84 in the sodium\/dicarboxylate cotransporter. J. Biol. Chem. 282:20213\u201320.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nature11542","volume":"491","author":"R Mancusso","year":"2012","unstructured":"Mancusso R, Gregorio GG, Liu Q, Wang DN. (2012) Structure and mechanism of a bacterial sodium-dependent dicarboxylate transporter. Nature. 491:622\u20137.","journal-title":"Nature"},{"key":"2201310_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali A, Blundell TL. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779\u2013815.","journal-title":"J. Mol. Biol."},{"key":"2201310_CR21","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1021\/acs.biochem.5b00388","volume":"54","author":"C Colas","year":"2015","unstructured":"Colas C, Pajor AM, Schlessinger A. (2015) Structure-based identification of inhibitors for the SLC13 family of Na(+)\/dicarboxylate cotransporters. Biochemistry. 54:4900\u20138.","journal-title":"Biochemistry"},{"key":"2201310_CR22","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"MY Shen","year":"2006","unstructured":"Shen MY, Sali A. (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci. 15:2507\u201324.","journal-title":"Protein Sci."},{"key":"2201310_CR23","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1110\/ps.036061.108","volume":"17","author":"D Eramian","year":"2008","unstructured":"Eramian D, Eswar N, Shen MY, Sali A. (2008) How well can the accuracy of comparative protein structure models be predicted? Protein Sci. 17:1881\u201393.","journal-title":"Protein Sci."},{"key":"2201310_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1528-1157.1973.tb03965.x","volume":"14","author":"TR Browne","year":"1973","unstructured":"Browne TR, Penry JK. (1973) Benzodiazepines in the treatment of epilepsy. A review. Epilepsia. 14:277\u2013310.","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"2201310_CR25","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/j.1528-1157.1986.tb05730.x","volume":"27","author":"MM Robertson","year":"1986","unstructured":"Robertson MM. (1986) Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: The place of clobazam. Epilepsia. 27(Suppl 1):S27\u201341.","journal-title":"Epilepsia"},{"key":"2201310_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1517\/13543784.15.10.1167","volume":"15","author":"TV Wuttke","year":"2006","unstructured":"Wuttke TV, Lerche H. (2006) Novel anticonvulsant drugs targeting voltage-dependent ion channels. Expert. Opin. Investig. Drugs. 15:1167\u201377.","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"2201310_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1517\/13543776.2013.782394","volume":"23","author":"M Aggarwal","year":"2013","unstructured":"Aggarwal M, Kondeti B, McKenna R. (2013) Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: A patent review. Expert. Opin. Ther. Pat. 23:717\u201324.","journal-title":"Expert. Opin. Ther. Pat."},{"key":"2201310_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ki.1990.265","volume":"38","author":"LL Hamm","year":"1990","unstructured":"Hamm LL. (1990) Renal handling of citrate. Kidney Int. 38:728\u201335.","journal-title":"Kidney Int."},{"key":"2201310_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000080259","volume":"98","author":"RJ Unwin","year":"2004","unstructured":"Unwin RJ, Capasso G, Shirley DG. (2004) An overview of divalent cation and citrate handling by the kidney. Nephron Physiol. 98:15\u201320.","journal-title":"Nephron Physiol."},{"key":"2201310_CR30","doi-asserted-by":"publisher","first-page":"F1093","DOI":"10.1152\/ajpcell.1996.271.6.C1808","volume":"271","author":"AM Pajor","year":"1996","unstructured":"Pajor AM, Sun N. (1996) Functional differences between rabbit and human Na+-dicarboxylate cotransporters, NaDC-1 and hNaDC-1. Am. J. Physiol. 271:F1093\u20139.","journal-title":"Am. J. Physiol."},{"key":"2201310_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1523-1755.2000.00155.x","volume":"58","author":"S Aruga","year":"2000","unstructured":"Aruga S, et al. (2000) Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int. 58:206\u201315.","journal-title":"Kidney Int."},{"key":"2201310_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10545-010-9268-2","volume":"34","author":"K Brauburger","year":"2011","unstructured":"Brauburger K, Burckhardt G, Burckhardt BC. (2011) The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons. J. Inherit. Metab. Dis. 34:477\u201382.","journal-title":"J. Inherit. Metab. Dis."},{"key":"2201310_CR33","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1074\/jbc.274.6.3422","volume":"274","author":"R Kekuda","year":"1999","unstructured":"Kekuda R, et al. (1999) Primary structure and functional characteristics of a mammalian sodium-coupled high affinity dicarboxylate transporter. J. Biol. Chem. 274:3422\u20139.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR34","doi-asserted-by":"publisher","first-page":"F1026","DOI":"10.1152\/ajprenal.00169.2011","volume":"301","author":"M Kaufhold","year":"2011","unstructured":"Kaufhold M, et al. (2011) Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am. J. Physiol. Renal Physiol. 301:F1026\u201334.","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2201310_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/358761a0","volume":"358","author":"GM Denning","year":"1992","unstructured":"Denning GM, et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 358:761\u20134.","journal-title":"Nature"},{"key":"2201310_CR36","doi-asserted-by":"publisher","first-page":"45083","DOI":"10.1074\/jbc.M111.293282","volume":"286","author":"L Suaud","year":"2011","unstructured":"Suaud L, et al. (2011) 4-Phenylbutyrate stimulates Hsp70 expression through the Elp2 component of elongator and STAT-3 in cystic fibrosis epithelial cells. J. Biol. Chem. 286:45083\u201392.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR37","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1021\/bi052064y","volume":"45","author":"AD Joshi","year":"2006","unstructured":"Joshi AD, Pajor AM. (2006) Role of conserved prolines in the structure and function of the Na+\/dicarboxylate cotransporter 1, NaDC1. Biochemistry. 45:4231\u20139.","journal-title":"Biochemistry"},{"key":"2201310_CR38","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/glia.22814","volume":"63","author":"M Schrodl-Haussel","year":"2015","unstructured":"Schrodl-Haussel M, Theparambil SM, Deitmer JW, Roussa E. (2015) Regulation of functional expression of the electrogenic sodium bicarbonate cotransporter 1, NBCe1 (SLC4A4), in mouse astrocytes. Glia. 63:1226\u201339.","journal-title":"Glia"},{"key":"2201310_CR39","doi-asserted-by":"publisher","first-page":"33338","DOI":"10.1074\/jbc.M200310200","volume":"277","author":"A Ikari","year":"2002","unstructured":"Ikari A, Nakano M, Kawano K, Suketa Y. (2002) Up-regulation of sodium-dependent glucose transporter by interaction with heat shock protein 70. J. Biol. Chem. 277:33338\u201343.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR40","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.2337\/dc10-0663","volume":"33","author":"A Iaconelli","year":"2010","unstructured":"Iaconelli A, et al. (2010) Effect of oral sebacic acid on postprandial glycemia, insulinemia, and glucose rate of appearance in type 2 diabetes. Diabetes Care. 33:2327\u201332.","journal-title":"Diabetes Care"},{"key":"2201310_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.seizure.2016.01.011","volume":"35","author":"HR Kass","year":"2016","unstructured":"Kass HR, et al. (2016) Use of dietary therapies amongst patients with GLUT1 deficiency syndrome. Seizure. 35:83\u201387.","journal-title":"Seizure"},{"key":"2201310_CR42","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1681\/ASN.2013010080","volume":"24","author":"E Ohana","year":"2013","unstructured":"Ohana E, Shcheynikov N, Moe OW, Muallem S. (2013) SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis. J. Am. Soc. Nephrol. 24:1617\u201326.","journal-title":"J. Am. Soc. Nephrol."},{"key":"2201310_CR43","first-page":"1007","volume":"1","author":"EF Kirby","year":"2013","unstructured":"Kirby EF, Heard AS, Wang XR. (2013) Enhancing the potency of F508del correction: a multi-layer combinational approach to drug discovery for cystic fibrosis. J. Pharmacol. Clin. Toxicol. 1:1007.","journal-title":"J. Pharmacol. Clin. Toxicol."},{"key":"2201310_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/embor.2010.51","volume":"11","author":"MP Mazurek","year":"2010","unstructured":"Mazurek MP, et al. (2010) Molecular origin of plasma membrane citrate transporter in human prostate epithelial cells. EMBO Rep. 11:431\u20137.","journal-title":"EMBO Rep."},{"key":"2201310_CR45","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.aaa1299","volume":"347","author":"N Sada","year":"2015","unstructured":"Sada N, Lee S, Katsu T, Otsuki T, et al. (2015) Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science. 347:1362\u20137.","journal-title":"Science"},{"key":"2201310_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/psp4.12062","volume":"5","author":"Z Li","year":"2016","unstructured":"Li Z, Erion DM, Maurer TS. (2016) Model-based assessment of plasma citrate flux into the liver: Implications for NaCT as a therapeutic target. CPT Pharmacometrics Syst. Pharmacol. 5:132\u20139.","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"2201310_CR47","doi-asserted-by":"publisher","first-page":"39469","DOI":"10.1074\/jbc.M207072200","volume":"277","author":"K Inoue","year":"2002","unstructured":"Inoue K, Zhuang L, Maddox DM, Smith SB, et al. (2002) Structure, function and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J. Biol. Chem. 277:39469\u201376.","journal-title":"J. Biol. Chem."},{"key":"2201310_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1042\/bj20031261","volume":"378","author":"K Inoue","year":"2004","unstructured":"Inoue K, Fei YJ, Zhuang L, Gopal E, et al. (2004) Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates. Biochem. J. 378:949\u201357.","journal-title":"Biochem. J."},{"key":"2201310_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cmet.2011.06.009","volume":"14","author":"AL Birkenfeld","year":"2011","unstructured":"Birkenfeld AL, Lee HY, Guebre-Egziabher F, Alves TC, et al. (2011) Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab. 14:184\u201395.","journal-title":"Cell Metab."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2016.00077\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2016.00077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T01:34:35Z","timestamp":1554514475000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2016.00077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2201310"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2016.00077","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"22 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}